Thumbay to launch longevity medicine programmes with Switzerland’s Geneva College
Mangalore Today News Network
Ajman, July 14, 2026: Thumbay Group has signed a landmark Memorandum of Understanding (MoU) with the Geneva College of Longevity Science (GCLS), Switzerland, to introduce the UAE’s first structured academic programmes in Longevity Medicine, Healthy Ageing, Preventive Healthcare, and Precision Health.
The programmes will be offered through the newly established Thumbay Institute of Longevity Medicine, making Gulf Medical University (GMU) the first private medical university in the UAE to provide formal academic education in the rapidly emerging field of longevity medicine.
The partnership brings together GCLS—the world’s first higher education institution dedicated exclusively to longevity science—and GMU’s academic expertise, supported by the extensive clinical network of Thumbay Healthcare. The collaboration aims to advance education, research, innovation, and professional development in longevity medicine across the Middle East.
According to the institutions, the initiative aligns with the UAE’s vision of becoming a global hub for advanced healthcare, preventive medicine, and medical innovation, while strengthening the country’s position as a regional leader in longevity science.
As part of the collaboration, the Thumbay Institute of Longevity Medicine will launch six internationally developed professional certificate programmes in partnership with GCLS. These include:
* Professional Certificate in Clinical Longevity Medicine
* Professional Certificate in Longevity Physiotherapy
* Professional Certificate in Longevity Nutrition
* Professional Certificate in Longevity Fitness
* Professional Certificate in Peptide Medicine
* Professional Certificate in Artificial Intelligence in Healthcare
The hybrid programmes will run over three months, with an initial intake of around 100 participants for each course.
Designed for physicians, pharmacists, nurses, physiotherapists, nutritionists, fitness professionals, and allied healthcare practitioners, the courses will combine Swiss academic expertise with GMU’s clinical faculty, simulation facilities, and integrated academic health system.
Participants will study internationally benchmarked curricula developed by GCLS and delivered by visiting international faculty and regional clinical experts. The programmes will also offer academic progression pathways into advanced studies in longevity science.
A recent GCLS Global Longevity Physician Survey 2026, which gathered responses from physicians across six continents, found that 99% reported increasing patient demand for longevity medicine, with 44% witnessing demand growth of more than 50% over the past three years. The survey also found that 83% of respondents believe healthcare will increasingly focus on prevention, while 76% expect significant lifespan extension to become achievable within the next two decades.
Thumbay Group Founder President Dr. Thumbay Moideen said the collaboration would bring world-class Swiss academic standards to the UAE and equip healthcare professionals with the skills required for the future of medicine.
GCLS President Dr. Dominik Thor said longevity medicine is becoming an essential part of modern healthcare and requires structured education, clinical standards, and credible training infrastructure. He described Gulf Medical University as an ideal partner to help establish that foundation in the Middle East.
The MoU outlines a phased collaboration beginning with education and professional development, with plans to expand into co-branded conferences, workshops, symposiums, and other joint initiatives. All programmes will comply with the relevant health authorities’ regulations.
Admissions are now open for the 2026–27 academic year, with applications for the first batch closing ahead of the September–October 2026 intake. GMU is offering more than 50 academic programmes for the upcoming academic year.